I recently purchased some products and I must say I am impressed. The quality is excellent and I am really satisfied with my purchase. The customer service was also exceptional. I would definitely recommend them to others.
Questions about PLUVIA AS
What is PLUVIA AS?
PLUVIA AS is a spin-out from the University of Bergen in Norway that develops innovative therapies for patients with rare genetic disorders. The company focuses on creating small molecule pharmacological chaperones to stabilize and correct protein misfolding in loss-of-function diseases. Their lead development program targets phenylketonuria (PKU), a rare disorder caused by mutations in the enzyme phenylalanine hydroxylase that lead to toxic phenylalanine accumulation in the brain.
Which specific diseases is PLUVIA AS targeting with its current research?
The company's primary focus is developing a drug to improve the quality of life for children affected by the rare, congenital disease disorder known as phenylketonuria (PKU). They aim to leverage their unique drug discovery platform to target multiple rare diseases caused by protein misfolding beyond just PKU.
What is the main therapeutic candidate PLUVIA AS is currently developing?
According to the company's own website, their lead development program is specifically focusing on phenylketonuria (PKU). They intend to use their drug discovery platform to address multiple rare diseases that stem from protein misfolding issues.
What is the name of the drug candidate PLUVIA AS is developing for PKU?
The therapeutic candidate being developed is named PBAS499. This candidate is intended to stabilize and correct the misfolding of proteins involved in selected loss-of-function diseases, thereby rescuing the enzymatic activity needed to modify the disease.
Where is PLUVIA AS based and how is it connected to academia?
PLUVIA AS is located in Norway and operates as a spin-out from the University of Bergen. The company is based in Western Norway and is working to commercialize decade-long research on protein structure and protein misfolding.
Who are the recent investors supporting PLUVIA AS's drug development program?
The company recently announced that Mid Atlantic Bio Angels and Tidligfasekapital Vestland are investing in their drug development program. These new investors joined existing investors Sarsia and Investinor to support final preclinical development steps towards First-in-Human studies for PBAS499.
Who is the current CEO of PLuvia Biotech and what is their background?
Deborah Ramsdell was appointed as the new CEO of Pluvia Biotech in August 2026. She brings more than three decades of biotechnology leadership, regulatory, and clinical development experience with a strong focus on rare diseases.
What themes do multiple customer reviews on Trustburn share about PLUVIA AS?
Some reviewers on Trustburn praise the company for having exceptional customer service and top-notch products. Multiple reviewers mentioned that the team is always ready to help and answer any questions, describing the service as superb and the products as of the highest quality.
What is the current Trustburn rating and how many reviews does PLUVIA AS have?
The company has received a Trustburn rating of 4 out of 5 from 8 reviews. The reviews range from 3 to 5 stars, with the most recent reviews dating back to September 2023.
How does PLUVIA AS compare to other entities mentioned in recent news?
The company announced in May 2026 that the US PKU patient advocacy organization, the NPKUA, recently announced an investment from its membership base of experienced life science and pharmaceutical professionals to support Pluvia as it advances toward clinical development.
What are the next steps for PLUVIA AS according to their official announcements?
The company's website states that they are preparing to move PBAS499 into the clinic and look forward to working with the team, Board, investors, and the PKU community to bring a meaningful new treatment option to people living with PKU.
What is the historical research foundation behind PLUVIA AS's work?
The company's website states that they are working to commercialize decade-long research on protein structure and protein misfolding, which forms the basis of their therapeutic approach.
What is the official website of PLUVIA AS?
The official website of PLUVIA AS is pluviabiotech.com.
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
Based on reviews, listing data and the company's website. Verify anything important with the company directly.
PLUVIA AS is absolutely amazing! Their products are outstanding and their customer service is superb. I'm extremely happy with my experience and I will definitely be a loyal customer.
I had a fantastic experience with PLUVIA AS. Their products are of the highest quality and their customer service is exceptional. Highly recommended! 😊👏
I recently purchased some items from a biotech company and I was really satisfied with the quality of the products. The customer service was also very friendly and helpful throughout the whole process.
PLUVIA AS is the best! Their products are amazing and I can't even describe how happy I am with their service. Their team is always there to answer any questions and provide assistance.
👍 I can't express enough how much I love PLUVIA AS. Their products are incredible and their customer service is top-notch. The team is always ready to help and answer any questions. I highly recommend them!
PLUVIA AS has exceeded my expectations. Their products are of the highest quality and their customer service is top-notch. I highly recommend them to anyone in need of biotech solutions. Keep up the good work!
I am very impressed with PLUVIA AS. Their products are top-notch and their customer service is excellent. I had a great experience working with them and I highly recommend their services.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About PLUVIA AS
PLUVIA AS is developing a drug that will improve the quality of life of children affected by the rare, congenital disease disorder.
- Website
- pluviabiotech.com
